|
|
|
肽酰脯氨酰顺式/反式异构酶pin1对调控pkb/akt稳定性和激活磷酸化非常重要 |
|
|
|
|
|
Peptidyl-prolyl cis/trans isomerase pin1 is critical for the regulation of pkb/akt stability and activation phosphorylation |
|
|
|
|
|
Liao, Y., Wei, Y., Zhou, X., Yang, J.-Y., Dai, C., Chen, Y.-J., Agarwal, N.K., Sarbassov, D., Shi, D., Yu, D., Hung, M.-C. 2009/7/29 13:49:00 |
|
【发表评论】
|
|
|
|
打印|
推荐给好友
|
|
|
Oncogene, 2009, Volume 28, Issue 26
|
|
|
|
|
|
|
The serine/threonine protein kinase B (PKB, also known as Akt) plays a pivotal role in diverse cellular functions. Elevated expression of activated Akt has been detected in a wide variety of human cancers; however, the mechanism of Akt protein stability regulation remains unclear. In this study, we showed a strong correlation between the expression levels of an oncogenic peptidyl-prolyl cis/trans isomerase Pin1 and levels of Akt phosphorylation at S473 in multiple cancer types (P0.0001). Akt-pS473 status combined with Pin1 expression levels predicted a poorer prognosis than did either one alone in patients with breast cancer (P0.0052). We further showed that Pin1 regulated Akt stability and phosphorylation on S473 through the phosphorylated Thr-Pro motifs of Akt. These motifs are conserved evolutionary and are required for the maintenance of Akt stability and its interaction with Pin1. In addition, repressing Pin1 expression through either homologue Pin1 knockout or small interfering RNA-mediated knockingdown compromised its ability to protect Akt from degradation. Our results show how Akt protein stability is regulated by the peptidyl-prolyl cis/trans isomerase Pin1 and highlight the importance of this oncogenic network in human disease pathogenesis. © 2009 Macmillan Publishers Limited All rights reserved.
|
|
|
|
|
|
|
Correspondence Address: Yang, J.-Y.; Department of Molecular Pathology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States; email:yongliao@mdanderson.org |
|
|
|
|
|
|
|
|
|
|
请登录后发表评论,点击此处登录。
|
|
|
疾病资源中心
王燕燕 王曙
上海交通大学附属瑞金医院内分泌科
患者,女,69岁。2009年1月无明显诱因下出现乏力,当时程度较轻,未予以重视。2009年3月患者乏力症状加重,尿色逐渐加深,大便习惯改变,颜色变淡。4月18日入我院感染科治疗,诉轻度头晕、心慌,体重减轻10kg。无肝区疼痛,无发热,无腹痛、腹泻、腹胀、里急后重,无恶性、呕吐等。入院半月前于外院就诊,查肝功能:ALT 601IU/L,AST 785IU/L,TBIL 97.7umol/L,白蛋白 41g/L,甲状腺功能:游离T3 30.6pmol/L,游离T4 51.9pmol/L,心电图示快速房颤。
医学数据库
|